Today, it is one of the most commonly discussed treatments for obesity. Conversations that once happened quietly behind closed doors are now taking place openly in GP surgeries, workplaces and family homes. More people are asking questions about bariatric surgery, weight loss injections and long-term obesity treatment than ever before.

This growing interest is not simply about losing weight. It reflects a broader shift in how obesity is understood.

For years, obesity was viewed primarily as a lifestyle issue. The advice was often straightforward: eat less, move more and try harder. While healthy eating and physical activity remain important, we now understand that obesity is a complex chronic disease influenced by genetics, hormones, metabolism, environment and psychological factors.

As that understanding has evolved, so too has the willingness of patients and healthcare professionals to consider treatments that go beyond traditional dieting.

One of those treatments is gastric sleeve surgery.

Ireland is Facing a Growing Obesity Challenge

The increasing popularity of gastric sleeve surgery cannot be separated from the reality of obesity in Ireland.

According to the latest Healthy Ireland data discussed in the Oireachtas, 21% of adults in Ireland are living with obesity, while a further 35% are classified as overweight. Together, that means more than half of the adult population is carrying excess weight.

The issue extends beyond adults. Research published by the HSE found that almost one in five primary school children in Ireland are living with overweight or obesity.

These figures matter because obesity is closely linked to a range of serious health conditions including:

• Type 2 diabetes
• High blood pressure
• Sleep apnoea
• Fatty liver disease
• Joint problems
• Heart disease
• Certain cancers

For many people, obesity becomes much more than a number on the scales. It begins to affect energy levels, mobility, confidence, relationships and long-term health.

As awareness of these risks grows, more people are seeking treatments that offer durable and meaningful results.

People are Beginning to Understand that Obesity is a Medical Condition

One of the biggest changes in recent years has been the way obesity is viewed by both patients and healthcare professionals.

Clinical guidelines in Ireland now recognise obesity as a chronic disease rather than simply a lifestyle issue. Experts increasingly acknowledge that many patients are fighting biological mechanisms that actively resist weight loss.

This shift is important.

When people understand that obesity is a medical condition, they become more open to medical treatments. Just as nobody would expect high blood pressure or asthma to be solved through willpower alone, obesity often requires specialist intervention.

For some patients, that intervention may involve weight loss medication. For others, it may involve bariatric surgery.

Increasingly, both approaches are being viewed as part of the same treatment pathway rather than competing alternatives.

Weight Loss Injections have Increased Awareness of Obesity Treatment

The rise of medications such as Ozempic and Mounjaro has generated enormous public interest in obesity treatment.

Many people who had never previously spoken to their GP about their weight are now doing so. This has helped reduce stigma and encouraged more conversations about obesity management.

Interestingly, the popularity of weight loss injections has also increased awareness of bariatric surgery.

Patients are becoming more informed about the different treatment options available. They are learning that obesity treatment exists on a spectrum, ranging from lifestyle support and medication to procedures such as gastric sleeve surgery, gastric bypass and SADI-S.

Rather than replacing surgery, these medications have often acted as a gateway to broader discussions about long-term obesity care.

Gastric Sleeve Surgery Offers Long-Term Results

Another reason gastric sleeve surgery is becoming more popular is that patients are increasingly focused on long-term outcomes.

Most people seeking obesity treatment have already tried multiple diets. Many have experienced the frustration of losing weight only to regain it months or years later.

What attracts many patients to gastric sleeve surgery is its ability to produce significant and sustained weight loss.

The procedure works by removing a large portion of the stomach, creating a smaller sleeve-shaped stomach. While this reduces the amount of food that can be consumed, it also affects hormones involved in hunger and appetite regulation.

Patients often report that the constant battle with hunger becomes easier to manage after surgery.

Importantly, the benefits extend beyond weight loss. Gastric sleeve surgery has been shown to improve or even resolve many obesity-related conditions, particularly type 2 diabetes, hypertension and sleep apnoea.

For patients who have spent years managing multiple health conditions, this can be life-changing.

Advances in Surgical Technology have Improved Confidence

Modern bariatric surgery looks very different from the procedures performed decades ago.

Minimally invasive techniques have transformed patient experience. Smaller incisions, reduced pain and faster recovery times have made surgery more accessible and less intimidating.

The development of robotic bariatric surgery has taken this even further.

Robotic technology allows surgeons to operate with enhanced precision and control, which can be particularly beneficial in patients with severe obesity or complex anatomy.

Blackrock WeightCare has seen firsthand how advances in surgical technology continue to improve patient outcomes and recovery.

More GPs are Referring Patients Earlier

There has also been a noticeable change within primary care.

Many GPs now recognise that waiting until obesity-related complications become severe may not be in the patient’s best interests.

Instead, referral for bariatric assessment is increasingly being considered earlier, particularly for patients with:

• Type 2 diabetes
• Sleep apnoea
• Hypertension
• Severe obesity
• Repeated unsuccessful attempts at weight loss

This does not mean every referred patient will undergo surgery. It simply means they have the opportunity to discuss all available treatment options with a specialist team.

Earlier conversations often lead to better outcomes.

The Conversation around Bariatric Surgery is Changing

Perhaps the biggest reason gastric sleeve surgery is becoming more popular in Ireland is that the conversation itself has changed.

Patients are no longer asking whether obesity deserves treatment.

They are asking which treatment is most appropriate for their situation.

Healthcare policy is evolving too. Recent discussions around a new National Obesity Strategy and continued efforts to expand obesity services reflect growing recognition that obesity requires structured medical care and long-term support.

The focus is gradually moving away from blame and towards treatment.

That is good news for patients.

Looking Beyond Weight Loss

For many people considering gastric sleeve surgery, the goal is not simply to lose weight.

It is to walk without pain.

To reduce diabetes medication.

To sleep better.

To play with children or grandchildren without becoming exhausted.

To improve health, mobility and quality of life.

Those are the outcomes that matter most.

At Blackrock WeightCare, based at Blackrock Clinic, we understand that every patient’s journey is different. Some patients may benefit from medical weight management, while others may be suitable for gastric sleeve surgery, gastric bypass or SADI-S. The most important step is understanding your options and receiving advice tailored to your individual health needs.

If you would like to learn more about gastric sleeve surgery in Ireland or discuss whether bariatric surgery may be right for you, our team is here to help.

Speak with our team directly on 01 255 2479.

Your Health. We Care.

The post Why Gastric Sleeve Surgery is Becoming More Popular in Ireland appeared first on Blackrock WeightCare.

When patients first enquire about weight loss surgery at Blackrock WeightCare, one of the first questions they ask is about cost. And one of the first things that surprises them is the answer: if you have private health insurance in Ireland and you meet the clinical criteria, there is a strong chance your surgery is already covered.

This is, as one of our own blog posts has noted, something of a hidden secret. Many patients assume bariatric surgery is an out-of-pocket expense — a luxury or an elective procedure. In reality, it is a clinically indicated medical treatment for a serious chronic condition, and Ireland’s three main insurers — VHI, Laya Healthcare, and Irish Life Health — all include bariatric surgery under qualifying plans at approved hospitals including Blackrock Clinic.

What Are the Eligibility Criteria?

Irish health insurers generally follow internationally recognised clinical guidelines when assessing eligibility for bariatric surgery. While specific requirements vary by insurer and plan, the typical criteria are:

Standard Clinical Eligibility Criteria

• BMI of 40 or above— regardless of other health conditions
• BMI of 35 or abovewith at least one significant obesity-related comorbidity such as type 2 diabetes, hypertension, sleep apnoea, or cardiovascular disease
• Evidence of previous attemptsat non-surgical weight management
• No contraindicationsto bariatric surgery — assessed through pre-operative evaluation
• Psychological suitability— assessed by a psychologist as part of the pre-operative programme
• Age typically18–65 years, though assessment is made case by case

Insurers may also require a minimum waiting period on the policy before a claim for planned surgical procedures can be made. This is known as a waiting period and typically applies to new policies. If you are on an existing policy and have not previously made a claim for bariatric surgery, this waiting period may already have passed.

Which Procedures Are Covered?

The most commonly covered procedures at Blackrock WeightCare include:

The post Does Irish Health Insurance Cover Weight Loss Surgery? appeared first on Blackrock WeightCare.

Many patients considering weight loss surgery in Ireland focus, understandably, on what happens in the first year. The weight loss is rapid, the changes are visible, and the impact on energy and health is often transformative. But the question I always want patients to think about is a longer one: what does this look like in ten years?

https://blackrockweightcare.ie/weight-loss-surgery-dublinThe answer, based on decades of high-quality evidence, is one of the most compelling stories in modern medicine. Bariatric surgery is not just about weight. It is about adding years to your life, reducing your risk of cardiovascular disease, cancer, and diabetes, and sustaining those benefits for the long term — not for months, but for decades.

Here is what the evidence actually shows.

The Big Picture: What 20 Years of Data Tells Us

The most authoritative long-term evidence comes from the Swedish Obese Subjects (SOS) study — a landmark prospective study that enrolled over 4,000 patients with obesity from 1987 to 2001 and followed them for up to 20 years. It remains the most comprehensive long-term investigation of bariatric surgery ever conducted.

Evidence · New England Journal of Medicine, 2020 — SOS Study

The SOS study found that, over 20 years of follow-up, patients who had bariatric surgery had an adjusted median life expectancy approximately 3 years longer than matched controls receiving usual obesity care. The hazard ratio for overall mortality was 0.77 — a 23% reduction. Cardiovascular mortality was reduced by 30%. The 90-day postoperative mortality in the surgical group was 0.2%.

These are not small improvements. A 3-year gain in life expectancy from a single intervention is a result that rivals many of the most celebrated treatments in cardiovascular medicine. And unlike medication, the effect does not stop when you stop taking something – because there is nothing to stop taking.

Year by Year: What to Expect

Year 1 — Rapid Transformation

The first year typically sees the most dramatic change. Most patients experience their fastest rate of weight loss in months 1–12.

• Average total body weight loss of 25–35% in the first year depending on procedure
• Type 2 diabetes improves or resolves — often within weeks of surgery, before major weight loss
• Blood pressure, sleep apnoea and joint pain typically improve significantly
• Energy levels, mobility and quality of life improve substantially

Years 2–5 — Consolidation

Weight loss typically slows and stabilises after the first 12–18 months. Some degree of weight regain is normal and expected in most patients — this does not represent failure.

• SOS study: mean weight loss of 23% at 2 years, stabilising to approximately 17% at 10 years
• Comorbidity resolution sustained — diabetes remission maintained in the majority
• The SLEEVEPASS trial (JAMA Surgery, 2022) confirmed sustainable weight loss for both sleeve and bypass at 10 years
• Cardiovascular risk factors continue to improve relative to non-surgical controls

Years 5–10 — Long-Term Durability

The defining period for durability. This is where bariatric surgery’s advantage over medication becomes most stark — medically-managed weight loss almost universally returns without ongoing treatment. Surgically-achieved weight loss largely persists.

• A systematic review and meta-analysis (O’Brien et al., Obesity Surgery, 2019) covering 57 datasets found all major bariatric procedures associated with durable weight loss at 10+ years
• Greater than 50% excess weight loss maintained for all current procedures at 10 years in the meta-analysis
• Mortality benefit becomes clearly established — SOS data shows advantage emerging over 10–13 years of follow-up
• Reduced incidence of myocardial infarction (adjusted HR 0.71) and stroke (adjusted HR 0.66) vs controls

15 Years and Beyond

The most compelling long-term data. Very few medical interventions for chronic disease can show benefits at this timeframe.

• SOS study: mean weight change of −16% at 15 years and −18% at 20 years in surgical group; essentially 0% in controls
• Cancer incidence reduced by 42% in women in the surgical group in the SOS study (men: no statistically significant difference)
• Life expectancy benefit sustained across all follow-up periods studied
• Patients with diabetes who achieved remission showed further reduction in long-term mortality risk

What About Weight Regain?

This is a question I encourage every patient to raise — because it deserves an honest answer. Some degree of weight regain after bariatric surgery is common and well-documented. It does not mean the surgery has failed, and it does not erase the benefits.

The SOS study data shows that even accounting for partial weight regain over time, surgical patients maintained substantially greater weight loss than non-surgical controls at every time point measured — 2, 10, 15 and 20 years. The cardiovascular and mortality benefits persisted regardless of the degree of regain.

Where significant weight regain does occur, we now have additional tools — including GLP-1 medication used as an adjunct — to help patients get back on track. This is part of what makes a comprehensive aftercare programme so important.

Beyond Weight: The Broader Health Benefits

Framing bariatric surgery purely as a weight loss procedure understates what it does. The most profound effects are often on conditions that carry the greatest health risk:

SOS Study · Summary of Key Outcomes at 10–20 Years

Type 2 diabetes: 83% reduction in new diagnoses; significant remission in those already diagnosed. Myocardial infarction: adjusted HR 0.71 (29% reduction). Stroke: adjusted HR 0.66 (34% reduction). Cancer (women): adjusted HR 0.58 (42% reduction). Overall mortality: adjusted HR 0.71–0.77 across follow-up periods. These outcomes are from published, peer-reviewed data in the New England Journal of Medicine and Journal of Internal Medicine.

These are not surrogate markers. These are deaths prevented, heart attacks avoided, and cancers that did not develop. The surgery that patients often fear most turns out to be one of the most powerful protective interventions available to people living with severe obesity.

Your Health. We Care.

The post What Does Bariatric Surgery Look Like after 5, 10 and 15 Years? appeared first on Blackrock WeightCare.

It is the frustration of someone who has watched obesity move through their family for years.

A mother who developed type 2 diabetes in her forties.
A father who struggled with weight and heart disease.
Siblings who are now facing the same pattern.

When that history is there, weight gain does not feel random. It feels inherited.

And many patients quietly ask the same question.

If this is in my genes, what chance do I really have?

The Role of Genetics in Obesity

Obesity is not simply the result of eating too much or moving too little. Modern research is clear that body weight is strongly influenced by biology. In fact, genetic factors can account for a significant proportion of a person’s tendency to gain weight.

Certain inherited traits affect how the brain regulates hunger and fullness. Some people feel satisfied quickly after a meal. Others feel persistent hunger even when they have eaten adequately. Some individuals burn energy more efficiently. Others store energy more readily.

When obesity runs in families, it is often because these biological signals are shared.

This is why two people can follow similar diets and exercise routines, yet experience very different results. One may lose weight steadily. The other may struggle constantly, losing and regaining weight despite genuine effort.

It is not a character flaw. It is physiology.

Why Weight Regain Is So Common

For patients with hereditary obesity, the body often defends its weight very aggressively.

When weight is lost through calorie restriction alone, the brain responds by increasing hunger hormones and reducing metabolic rate. The body interprets weight loss as a threat. It works to restore what has been lost.

If you are genetically predisposed, that response can be stronger and longer lasting.

This is why so many people describe years of dieting followed by regain. Over time, the cycle becomes exhausting. Confidence drops. Shame creeps in. And yet the underlying biology has never truly been addressed.

The Link With Diabetes and Other Conditions

Genetic obesity rarely exists in isolation. It is frequently associated with:

• Type 2 diabete
• High blood pressure
• Sleep apnoea
• Fatty liver disease
• Cardiovascular risk

In Ireland, we are seeing younger patients developing metabolic disease earlier than previous generations. A strong family history of diabetes or heart disease should not be ignored.

Obesity is not simply about weight. It is about long-term health risk.

Where Do Medications Like Ozempic and Mounjaro Fit

Treatments such as Ozempic and Mounjaro have changed how we approach obesity management. These medications act on gut hormones that regulate appetite and blood sugar. For many patients, they reduce constant hunger and make portion control achievable for the first time.

For individuals with moderate obesity, particularly those with early type 2 diabetes, these treatments can be very effective. They can reduce weight, improve HbA1c, and lower cardiovascular risk.

But for patients with severe obesity — particularly BMI over 40 or over 35 with significant medical complications — medication alone may not provide enough metabolic change to reverse established disease.

That does not mean medication has failed. It simply means the severity of the condition may require a more powerful intervention.

How Bariatric Surgery Addresses the Underlying Biology

Bariatric surgery, including gastric sleeve, gastric bypass and SADI-S, works at a deeper hormonal level.

It changes the communication between the gut and the brain. Hunger signals are reduced. Satiety improves. Insulin sensitivity increases. In many cases, blood sugar levels normalise rapidly after surgery, even before significant weight loss occurs.

For patients with hereditary obesity, this hormonal shift can counteract the biological drivers that have made weight control so difficult.

This is why bariatric surgery remains the most effective treatment for severe obesity and obesity-related type 2 diabetes. Long-term studies show sustained weight loss, high rates of diabetes remission and meaningful reductions in cardiovascular risk.

In Ireland and the UK, bariatric surgery is recognised as a medically necessary treatment for appropriate patients — not a cosmetic procedure.

Breaking a Pattern That Feels Inevitable

One of the most powerful moments in consultation is when a patient realises that their story does not have to follow the same path as their parents’.

If a parent required insulin in their fifties, that does not mean the same outcome is unavoidable.

If heart disease developed early in one generation, intervention can change the risk in the next.

Treating obesity effectively is not only about today. It is about reducing the likelihood of kidney disease, stroke, heart attack and mobility loss in the years ahead.

When obesity is genetic, early and appropriate treatment matters even more.

So Can Bariatric Surgery Help If Obesity Is Genetic

Yes. It can.

It does not erase your genes. But it can significantly reduce their impact.

For patients with severe or complex obesity, particularly those with a strong family history of metabolic disease, bariatric surgery offers the most durable improvement in weight, diabetes control and overall health risk.

The decision is never rushed. Assessment is careful. Medical treatment, including weight loss injections, may still have a role before or after surgery.

The goal is not simply weight reduction. The goal is long-term metabolic health.

You Are Not Alone In This

If obesity runs in your family and you feel that you have tried everything, it is important to understand that your experience is valid.

You may not lack discipline. You may be living with a chronic, genetically influenced disease that requires medical and possibly surgical care.

At Blackrock WeightCare, based at the Blackrock Clinic, we provide comprehensive obesity treatment including medical weight management and advanced bariatric surgery. Each patient is assessed individually, with careful consideration of family history, metabolic health and long-term goals.

If you would like to explore your options, you can begin by filling out a form on our website here or speak directly with our team on 01 255 2479.

Your Health. We Care.

The post Is Obesity Genetic, and Can Bariatric Surgery Help appeared first on Blackrock WeightCare.

If you are considering weight loss surgery in Ireland, one question comes up in almost every consultation: should I have the sleeve or the bypass?

It is the right question to ask. Both procedures are highly effective, both are proven to produce durable weight loss, and both are available at Blackrock WeightCare using Ireland’s first robotic bariatric surgery programme. But they work differently, suit different patients, and come with different long-term considerations.

There is no universal answer. But there is a best answer for you – and this guide will help you understand what that might be.

How Each Procedure Works

Gastric Sleeve (Sleeve Gastrectomy)

The stomach is permanently reduced to roughly 20% of its original size — forming a narrow, sleeve-shaped tube. This limits how much food you can eat and, critically, removes the portion of the stomach that produces most of the hunger hormone ghrelin. The result is that patients feel full faster and feel less hungry overall. There is no rerouting of the digestive system.

Gastric Bypass (Roux-en-Y Gastric Bypass)

A small stomach pouch is created at the top of the stomach, and the small intestine is rerouted to connect to it directly – bypassing the remainder of the stomach and the upper section of the small bowel. Food passes through a shorter digestive route. This produces powerful changes in gut hormones, and has particularly strong effects on conditions like type 2 diabetes, often producing remission before significant weight loss has even occurred.

How They Compare: The Evidence

Evidence · Lancet Diabetes & Endocrinology, 2025

The Oseberg trial — a long-term randomised controlled trial — found that gastric bypass was superior to sleeve gastrectomy for remission of type 2 diabetes at 5 years, with bypass patients more than twice as likely to achieve remission. Bypass also produced greater total weight loss and better outcomes for LDL cholesterol. The SleeveBypass trial (Lancet Regional Health, 2024) found the two procedures produced clinically comparable excess BMI loss at 5 years, though bypass showed advantages in total weight loss and cholesterol outcomes.

Who Is Each Procedure Best For?

Gastric Sleeve – Gastric Sleeve tends to suit patients who have no significant acid reflux, are looking for a technically simpler procedure, have a lower BMI range for surgery, do not have type 2 diabetes or have well-controlled diabetes, or wish to minimise the risk of nutritional complications.

Gastric Bypass – Gastric Bypass tends to suit patients who have type 2 diabetes or pre-diabetes, have significant acid reflux or GERD, have a higher BMI, have had a sleeve gastrectomy that produced insufficient weight loss, or where maximum metabolic benefit is the primary clinical goal.

It is important to be honest: these are guides, not rules. Individual anatomy, comorbidities, previous surgical history, and personal circumstances all factor into the recommendation. This is precisely why a thorough pre-operative assessment — including consultation with a dietitian, physician, and psychologist — is essential before any decision is made.

The landmark Swedish Obese Subjects (SOS) study — which followed over 4,000 patients for up to 20 years — found that bariatric surgery was associated with a 23% reduction in overall mortality compared to matched controls receiving usual care, and a 30% reduction in cardiovascular mortality. Surgery adds years to life. Both procedures share in this benefit.

A Note on Robotic Surgery

At Blackrock WeightCare, both sleeve gastrectomy and gastric bypass are available using Ireland’s first robotic bariatric surgery programme. Robotic-assisted surgery allows greater precision, improved visualisation, and can be particularly advantageous for patients with higher BMI or more complex anatomy. Mr Robb will advise at the consultation whether the robotic or laparoscopic technique is most appropriate for your procedure.

Your Health. We Care.

The post Gastric Sleeve vs Gastric Bypass: Which is Right for You? appeared first on Blackrock WeightCare.

The medical community’s understanding of obesity has undergone a significant evolution. Where it was once viewed primarily as a lifestyle issue — a comorbidity arising from poor choices — it is now increasingly classified as a chronic, progressive disease in its own right. This is not merely a semantic change. It has profound implications for how patients are assessed, counselled, and treated.

Obesity is now understood to be associated with more than 200 distinct health conditions. More significantly, it is no longer viewed as a consequence of those conditions — it is increasingly recognised as a driver of them. Adipose tissue, long dismissed as passive calorie storage, is now known to function as a highly active endocrine organ, secreting pro-inflammatory cytokines and metabolic mediators that exert systemic effects on the cardiovascular, hepatic, and renal systems.

“Obesity is not simply excess weight — it is a state of chronic biological dysfunction that reshapes the disease trajectory of multiple organ systems simultaneously.“

The Role of Visceral Adiposity

Not all fat is metabolically equivalent. At a healthy weight, the majority of adipose tissue is stored subcutaneously, where it functions as a relatively inert energy reserve. As fat mass increases, the body’s capacity for safe subcutaneous storage becomes overwhelmed, and lipid deposition shifts to visceral compartments — surrounding the liver, kidneys and heart.

Visceral adipose tissue is considerably more metabolically active than its subcutaneous counterpart. It exhibits higher lipolytic activity, generates excess free fatty acids, and produces pro-inflammatory mediators that enter the portal circulation directly. The downstream consequences — hepatic steatosis, insulin resistance, systemic inflammation, and accelerated cardiovascular risk — are well documented.

Genetic studies further suggest that individuals predisposed to visceral rather than subcutaneous fat storage carry a substantially elevated cardiometabolic risk profile, independent of total body weight.

Why Treatment Must Be Matched to the Individual

The emergence of GLP-1 receptor agonists has transformed the medical management of obesity, offering clinically meaningful weight reduction and cardiovascular benefit for many patients. However, the evidence is clear that these agents do not work uniformly. Approximately one in four patients with obesity does not achieve clinically significant weight loss with GLP-1 therapy alone — underscoring the heterogeneity of the condition and the need for a stratified treatment approach.

Bariatric surgery remains the most effective and durable intervention available for patients with severe obesity or those with significant metabolic comorbidities. Its benefits extend well beyond weight reduction: improvements in glycaemic control, blood pressure, hepatic steatosis, and cardiovascular risk are well established, and in many cases precede significant weight loss — suggesting mechanisms of action that go beyond caloric restriction alone.

The Diagnosis Gap — and Why Early Referral Matters

A further challenge is the persistent under-diagnosis of obesity in clinical practice. Recent data suggests that approximately 30% of individuals meeting the BMI threshold for obesity do not have a formal obesity diagnosis recorded. Earlier identification creates earlier opportunity — to intervene before comorbidities develop or compound, and to match patients to the treatment pathway most likely to be effective for their individual biology.

Blackrock WeightCare – Specialist Obesity Care in Dublin

Blackrock WeightCare provides comprehensive, evidence-based obesity treatment at the Blackrock Clinic. Our service offers bariatric surgical assessment and intervention, medical obesity management including GLP-1 therapies, and structured multidisciplinary follow-up – with a shared goal of delivering meaningful, sustained improvements in both weight and metabolic health.

For GPs considering referral, or for patients seeking specialist assessment, we welcome enquiries through our website. The right treatment, delivered at the right time, can change the long-term health trajectory of patients living with obesity.

Referring a patient or seeking a specialist consultation? We’d be glad to hear from you – 01 255 2479.

Your Health. We Care.

The post Obesity is a Disease of Biology, Not Behaviour – What the Latest Science Means for Treatment appeared first on Blackrock WeightCare.

If you have tried – really tried – to lose weight and found it almost impossible to keep off, there is something important you need to hear: your body is actively working against you. Not because you lack discipline. Not because you are not trying hard enough. But because of the way human biology is wired. 

New research is fundamentally changing how medicine understands obesity. Far from being a simple matter of eating less and moving more, obesity is now recognised as a chronic, systemic condition – one that involves the brain, the gut, the liver, the heart, and a remarkable organ most of us have never thought much about: fat tissue itself.

“Obesity is not a reflection of character. It is a biological condition – and like all biological conditions, it deserves proper medical treatment.”

Fat Tissue: The Hidden Organ Driving Your Health 

Most people think of body fat as inert – a passive store of excess calories. In reality, fat tissue is one of the most metabolically active organs in the body. It produces hormones, generates inflammatory signals, and communicates constantly with the brain and other organs. When fat accumulates in the wrong places – particularly around the abdominal organs – it stops functioning as a safe reservoir and starts actively disrupting the body’s normal processes.

This is why obesity is associated with so many seemingly unrelated health conditions: heart disease, type 2 diabetes, liver disease, joint problems, sleep apnoea, and even depression. It is not a coincidence – it is biology. The excess fat is driving inflammation and dysfunction throughout the body, often long before symptoms become obvious.

Why the Weight Comes Back

One of the most important and least talked about aspects of obesity is what happens when you lose weight. The body interprets any significant fat loss as a threat to survival. In response, it increases hunger hormones, reduces metabolic rate, and creates powerful cravings designed to bring your weight back up. This is not a lack of willpower. It is a deeply ingrained survival mechanism that has been shaped by millions of years of evolution.

This is also why short-term diets almost always fail in the long run, and why people often feel worse – more hungry, more obsessed with food – after losing weight than before. The body has shifted into defence mode.

There is No Single Solution – And That’s Why Expert Care Matters

Medical treatments for obesity have improved enormously in recent years. GLP-1 medications have helped many people achieve meaningful weight loss. But they don’t work for everyone – studies suggest up to a quarter of patients don’t achieve clinically significant results with medication alone. For others, bariatric surgery offers the most effective and durable long-term outcomes available.

The key is matching the right treatment to the right person – taking into account your individual biology, medical history, and goals. That is precisely what a specialist obesity service does.

Getting the Right Help in Dublin

At Blackrock WeightCare, based at the Blackrock Clinic, we take a comprehensive, evidence-based approach to obesity treatment. Whether your path involves medical management, bariatric surgery, or a combination of both, our team will work with you to build a treatment plan that fits your life – not a one-size-fits-all protocol.

If you have been struggling with your weight and feel you have run out of options, you have not. You may simply not yet have had access to the right support.

You can begin the conversation by visiting our contact page or speak directly with our team on 01 255 2479.

Your Health. We Care.

The post Why Losing Weight Is So Hard – And Why It’s Not About Willpower appeared first on Blackrock WeightCare.

A common concern we hear is this – Do I need to lose weight with injections first before I can be considered for bariatric surgery?

In many cases, the answer is ‘No’.

You Do Not Always Need Injections Before Surgery

Patients with BMI above 45, and particularly those above 50, are sometimes told they must reduce weight before surgery is even discussed. This can lead to months or even years spent trying medications first.

At Blackrock WeightCare, we regularly assess and treat high BMI and complex cases. Surgery is not automatically ruled out because your BMI is high. In fact, procedures such as SADI-S are specifically designed for patients who require a stronger metabolic effect.

If surgery is clinically appropriate, it can be planned safely without asking you to invest time and money into injections first.

Each case is assessed on its own merits.

When Injections May Be Helpful

That said, weight loss injections can sometimes be useful.

They may help:

• Improve blood sugar control before surgery
• Reduce liver size
• Optimise medical conditions
• Support short-term weight reduction in selected cases

But this is strategic and individual. It is not a requirement for everyone.

Injections should never be viewed as a mandatory first step before surgical assessment.

High BMI Is Not an Automatic Barrier

Severe obesity often comes with additional conditions such as Type 2 diabetes, sleep apnoea, joint disease or cardiovascular risk. These patients need specialist input, not delay.

At Blackrock WeightCare, complex and high BMI patients are routinely assessed by Mr William Robb, an experienced Upper GI and Robotic Bariatric Surgeon. Careful evaluation determines:

• Whether surgery is safe now
• Whether optimisation is required first
• Which procedure offers the best long-term outcome

In many cases, metabolic surgery such as Gastric Sleeve or SADI-S provides more durable weight loss and stronger metabolic improvement than injections alone.

Why Expert Assessment Matters First

Starting injections without specialist advice can lead to:

• Modest short-term weight loss but no long-term plan
• Weight regain after stopping medication
• Delayed definitive treatment
• Additional financial cost

Obesity is a chronic disease. The treatment pathway should be planned properly from the outset.

An expert consultation allows you to understand:

• Whether injections are appropriate
• Whether surgery is the more effective option
• Whether a combined approach makes sense
• What is safest given your BMI and medical history

The right decision depends on your health, not on trends.

The Bottom Line

Weight loss injections can play a really positive role in obesity treatment. They are very useful tools in well selected and educated patients.

But you do not need to “prove yourself” with injections before being considered for surgery.

If you have a high BMI or complex medical history, the first step should always be specialist assessment. That way, you avoid unnecessary delay and move forward with a clear plan. Surgery and medication are very often complementary in the treatment of obesity – rather than it being the case of one or the other. 

If you would like to discuss your options, you can enquire here or speak directly with our team on 01 255 2479.

Your Health. We Care.

The post Can Weight Loss Injections Help You Qualify for Surgery appeared first on Blackrock WeightCare.

Choosing bariatric surgery is not simply about losing weight. It is about improving health, reducing long-term medical risk and selecting the right procedure for your BMI, metabolic condition and overall health profile.

Patients across Ireland, the UK and Northern Ireland often compare three main procedures:

• Gastric Sleeve
• Gastric Bypass
• SADI-S

Each operation works differently. Understanding those differences is essential before making a decision.

Understanding the Three Procedures

Gastric Sleeve (Sleeve Gastrectomy)

Gastric sleeve surgery involves removing approximately 70–80% of the stomach. The remaining stomach becomes a narrow tube.

It works by:

• Restricting food intake
• Reducing hunger hormones
• Promoting early fullness

It does not involve bypassing the intestine.

Sleeve surgery is commonly offered to patients with BMI 35–45 and can deliver strong, sustainable weight loss when appropriately selected.

Gastric Bypass (Roux-en-Y)

Gastric bypass creates a small stomach pouch and reroutes part of the small intestine.

It works through:

• Restriction
• Hormonal changes
• Reduced calorie absorption

It has a strong metabolic effect and is particularly effective in patients with type 2 diabetes.

Gastric bypass is suitable for BMI 35–55 and can also be appropriate in higher BMI patients depending on clinical circumstances.

SADI-S (Single Anastomosis Duodeno-Ileal Bypass with Sleeve)

SADI-S combines a sleeve gastrectomy with a longer intestinal bypass.

It provides:

• Restriction
• Powerful hormonal change
• Greater metabolic impact

It is particularly effective for:

• BMI 45–70+
• Severe type 2 diabetes
• High BMI patients requiring stronger long-term weight loss

SADI-S is technically more advanced and should be performed in experienced centres.

Clear Comparison: Sleeve vs Bypass vs SADI-S

Which Procedure Is Best for Higher BMI?

For patients with a BMI over 50, the strength, durability and metabolic impact of weight loss become especially important.

While gastric sleeve can be effective in selected patients, it may not provide sufficient long-term weight loss for individuals with BMI 60 and above.

Gastric bypass offers significant weight reduction and strong diabetes improvement, and remains an excellent option for many patients with severe obesity.

However, for patients with BMI 50–70+, SADI-S is often considered the most effective bariatric procedure due to its powerful metabolic effect and greater long-term weight loss potential. In experienced hands, it provides stronger hormonal changes and sustained results in patients with high BMI.

That said, the most appropriate procedure always depends on individual factors such as overall health, diabetes severity, previous surgeries and surgical risk profile. A personalised consultation is essential to determine which operation is safest and most effective for you.

Safety and Complexity

All bariatric procedures are safe when performed in experienced centres.

However, high BMI and complex cases require:

• Careful pre-operative optimisation
• Experienced anaesthetic management
• Technical precision
• Structured long-term follow-up

The surgeon’s experience is often more important than the name of the procedure itself.

Long-Term Outcomes

Long-term success is influenced by:

• Procedure selection
• Multidisciplinary support
• Nutritional follow-up
• Patient engagement

For some patients, sleeve is entirely appropriate. For others, especially those with higher BMI or complex metabolic disease, bypass or SADI-S may provide more durable results.

There is no single “best” operation for everyone.

Why Personalised Assessment Matters

Bariatric surgery is not a menu choice. It is a clinical decision.

The safest and most effective approach is to consult an experienced bariatric surgeon who understands:

• BMI-specific risks
• Metabolic disease
• Revision options
• Long-term nutritional management
• Robotic and advanced surgical techniques

An experienced surgeon can evaluate your individual profile and recommend the procedure most suited to your long-term health.

Expertise at Blackrock WeightCare

At Blackrock WeightCare, procedure selection is always personalised. Our team includes experienced surgeons, specialist nurses, dietitians and anaesthetists who guide patients carefully through the decision-making process.

Mr William Robb is one of the highest volume robotic surgeons in Europe and has performed more than 1,500 robotic surgical operations. His experience in complex and high BMI cases allows for careful selection of the most appropriate procedure, particularly where advanced techniques such as robotic SADI-S are considered.

Patients from Ireland, the UK and Northern Ireland seek specialist assessment not simply for surgery, but for clarity, safety and long-term results.

Choosing between sleeve, bypass, and SADI-S is not about selecting the most popular option. It is about choosing the right operation for you, guided by experience and evidence.

If you would like a personalised consultation to understand which procedure may suit you best, fill out an inquiry form here or call 01 255 2479.

Your Health. We Care.

The post Gastric Sleeve vs Gastric Bypass vs SADI-S appeared first on Blackrock WeightCare.

For patients living with obesity and type 2 diabetes, bariatric surgery is not simply weight loss surgery. It is metabolic surgery. In many cases, it can significantly improve diabetes control and, for some patients, lead to remission.

If you are researching bariatric surgery for type 2 diabetes in Ireland, understanding which procedure offers the best results is essential.

Why bariatric surgery works for type 2 diabetes

Bariatric procedures do more than restrict food intake. They change gut hormones, insulin sensitivity and glucose metabolism.

After surgery, many patients experience:

• Rapid improvement in blood sugar levels
• Reduced need for diabetic medication
• Lower insulin requirements
• Improved HbA1c
• Reduced cardiovascular risk 

These improvements often occur within days to weeks, even before significant weight loss happens.

For patients with obesity-related diabetes, surgery addresses the underlying metabolic dysfunction rather than simply treating symptoms.

Gastric sleeve and type 2 diabetes

Gastric sleeve surgery (sleeve gastrectomy) removes a portion of the stomach, reducing hunger hormones such as ghrelin and improving insulin sensitivity.

It is effective for:

• Patients with BMI 35–45
• Early or moderately severe type 2 diabetes
• Patients not requiring high-dose insulin 

Many patients experience significant improvement, and some achieve remission, particularly when diabetes duration is shorter.

However, in patients with long-standing or insulin-dependent diabetes, the metabolic effect may be less powerful than other procedures.

Gastric bypass and diabetes remission

Gastric bypass surgery has been performed for decades and has strong evidence supporting diabetes improvement and remission.

It works by:

• Restricting food intake
• Altering nutrient absorption
• Creating powerful hormonal changes that improve insulin response 

Gastric bypass is often recommended for:

• Patients with poorly controlled type 2 diabetes
• Higher BMI categories
• Those requiring insulin 

Remission rates are significant, particularly when surgery is performed earlier in the disease course.

SADI-S and severe type 2 diabetes

For patients with BMI over 45–50, or those with severe and insulin-dependent diabetes, SADI-S (Single Anastomosis Duodeno-Ileal Bypass with Sleeve) offers particularly strong metabolic benefits.

SADI-S combines:

• Sleeve gastrectomy
• A longer intestinal bypass
• Enhanced hormonal and metabolic impact 

This procedure is especially effective in:

• Long-standing diabetes
• High insulin requirements
• Severe obesity
• Patients declined elsewhere due to complexity 

At Blackrock WeightCare, we are leaders in robotic SADI-S surgery in Ireland. For high BMI patients with complex diabetes, SADI-S often provides greater total weight loss and more powerful metabolic control compared to other procedures.

Does bariatric surgery cure type 2 diabetes

The word “cure” is rarely used in medicine. However, many patients achieve remission, meaning normal blood sugar levels without diabetic medication.

The likelihood of remission depends on:

• Duration of diabetes
• Pancreatic beta cell function
• Pre-operative insulin use
• BMI
• Procedure type 

Earlier intervention generally leads to better outcomes.

Even when full remission is not achieved, most patients see:

• Reduced medication burden
• Lower insulin doses
• Improved cardiovascular risk profile 

For many, this significantly changes long-term health outcomes.

Choosing the best bariatric surgery for diabetes in Ireland

There is no single “best” procedure for everyone. The right operation depends on:

• BMI
• Severity and duration of diabetes
• Insulin dependency
• Reflux symptoms
• Previous abdominal surgery
• Overall medical complexity 

At Blackrock WeightCare, every patient undergoes a comprehensive multidisciplinary assessment. We tailor the procedure to the individual rather than applying a one-size-fits-all approach.

As one of the highest-volume robotic surgical operation centres in Europe, we specialise in complex and high BMI cases, particularly SADI-S for patients with advanced metabolic disease.

Why early referral matters

Type 2 diabetes is progressive. The longer it continues, the greater the risk of irreversible pancreatic damage.

Considering bariatric surgery earlier — rather than after years of escalating medication — can improve the chance of remission and reduce long-term complications.

If you are living with obesity and type 2 diabetes and want to understand your options for bariatric surgery in Ireland, a specialist assessment can provide clarity.

You can contact Blackrock WeightCare by filling the inquiry form here or by calling 01 255 2479.

Your Health. We Care.

The post Which bariatric surgery is best for type 2 diabetes in Ireland appeared first on Blackrock WeightCare.